John B. Fenn
John Bennett Fenn (June 15, 1917 – December 10, 2010) was an American chemist who, along with Koichi Tanaka and Kurt Wüthrich, was awarded the Nobel Prize in Chemistry in 2002 for his work in the development of methods for the identification and structure analyses of biological macromolecules, specifically for his pioneering work in the development of Electrospray Ionization (ESI), a technique used in mass spectrometry. This groundbreaking work has had a profound impact on the field of analytical chemistry, enabling scientists to analyze biological molecules in a way that was not possible before.
Early Life and Education
John B. Fenn was born in New York City, USA. He received his Bachelor of Science degree in chemistry from Berea College in Kentucky in 1937 and went on to complete his Ph.D. in chemistry at Yale University in 1940. His doctoral research focused on the mechanisms of chemical reactions, laying the groundwork for his later contributions to the field of mass spectrometry.
Career
After completing his Ph.D., Fenn embarked on a career in both academia and industry. He worked for several companies, including Monsanto and Project SQUID, a postwar research project on jet propulsion. In 1962, he returned to academia, joining the faculty of Yale University where he began his pioneering work on electrospray ionization. In 1994, he moved to Virginia Commonwealth University, where he continued his research until his retirement.
Nobel Prize
The Nobel Prize in Chemistry 2002 was awarded to John B. Fenn for his development of electrospray ionization for mass spectrometry, which made it possible to analyze biological macromolecules such as proteins and nucleic acids in a detailed and precise manner. This technique revolutionized the field of analytical chemistry, providing a tool that is essential for the fields of chemistry, biochemistry, and molecular biology. Fenn's work has enabled countless scientific discoveries and advancements, particularly in the understanding of the complex machinery of life.
Impact and Legacy
John B. Fenn's contributions to the field of chemistry, particularly through his development of electrospray ionization, have left a lasting legacy. His work has facilitated the growth of proteomics and other areas of research that rely on the analysis of large biomolecules. Today, ESI-MS is a cornerstone technique in laboratories around the world, used for a wide range of applications from drug discovery to environmental analysis.
Death
John B. Fenn passed away on December 10, 2010, at the age of 93. His passing was mourned by the scientific community, but his legacy lives on through the continued use and development of ESI-MS and its applications in science and medicine.
See Also
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD